Filing Details

Accession Number:
0000711377-17-000008
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-05-15 19:00:37
Reporting Period:
2017-05-11
Filing Date:
2017-05-15
Accepted Time:
2017-05-15 19:00:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168789 L James Herbert Neogen Corp
620 Lesher Place
Lansing MI 48912
Chairman & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-05-11 8,107 $39.61 890,319 No 4 M Direct
Common Stock Disposition 2017-05-11 8,107 $62.01 882,212 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2017-05-11 8,107 $0.00 8,107 $39.61
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
330,894 2019-10-31 No 4 M Direct
Footnotes
  1. Options were granted on 10/1/2014, have five year lives, and vest in equal annual 20% installments on each of the first five anniversary dates of the grant